Feldman DR - Search Results

1

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.

Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA. Casuscelli J, et al. Among authors: feldman dr. Eur Urol Focus. 2019 Jul;5(4):642-649. doi: 10.1016/j.euf.2017.09.008. Epub 2017 Sep 24. Eur Urol Focus. 2019. PMID: 28951115 Free PMC article.

2

Novel targets and therapies for metastatic renal cell carcinoma.

Feldman DR, Motzer RJ. Feldman DR, et al. Oncology (Williston Park). 2006 Dec;20(14):1745-53; discussion 1756. Oncology (Williston Park). 2006. PMID: 17263126 Free article. Review.

3

Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.

Feldman DR, Kondagunta GV, Ginsberg MS, Ishill N, Patil S, Cestaro J, Obbens E, Sheinfeld J, Bosl GJ, Motzer RJ. Feldman DR, et al. Invest New Drugs. 2007 Oct;25(5):487-90. doi: 10.1007/s10637-007-9059-2. Epub 2007 May 23. Invest New Drugs. 2007. PMID: 17520176 Clinical Trial.

4

Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Feldman DR, Martorella AJ, Robbins RJ, Motzer RJ. Feldman DR, et al. J Natl Cancer Inst. 2007 Jun 20;99(12):974-5; author reply 976-7. doi: 10.1093/jnci/djm006. Epub 2007 Jun 12. J Natl Cancer Inst. 2007. PMID: 17565156 No abstract available.

5

Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?

Feldman DR, Motzer RJ, Bajorin DF. Feldman DR, et al. Nat Clin Pract Urol. 2008 Feb;5(2):78-9. doi: 10.1038/ncpuro0999. Epub 2007 Dec 11. Nat Clin Pract Urol. 2008. PMID: 18073725 No abstract available.

6

Medical treatment of advanced testicular cancer.

Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Feldman DR, et al. JAMA. 2008 Feb 13;299(6):672-84. doi: 10.1001/jama.299.6.672. JAMA. 2008. PMID: 18270356 Review.

7

Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.

Jathavedam A, Feldman DR, Ishill N, Turkula S, Patil S, Bosl GJ, Motzer RJ, Weinstock DM. Jathavedam A, et al. Among authors: feldman dr. Biol Blood Marrow Transplant. 2008 May;14(5):595-600. doi: 10.1016/j.bbmt.2008.02.020. Biol Blood Marrow Transplant. 2008. PMID: 18410903 Free article.

8

Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma.

Feldman DR, Kondagunta GV, Schwartz L, Patil S, Ishill N, DeLuca J, Russo P, Motzer RJ. Feldman DR, et al. Clin Genitourin Cancer. 2008 Mar;6(1):25-30. doi: 10.3816/cgc.2008.n.004. Clin Genitourin Cancer. 2008. PMID: 18501079 Clinical Trial.

9

Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

Feldman DR, Baum MS, Ginsberg MS, Hassoun H, Flombaum CD, Velasco S, Fischer P, Ronnen E, Ishill N, Patil S, Motzer RJ. Feldman DR, et al. J Clin Oncol. 2009 Mar 20;27(9):1432-9. doi: 10.1200/JCO.2008.19.0108. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224847 Free PMC article. Clinical Trial.

10

Good-risk-advanced germ cell tumors: historical perspective and current standards of care.

Feldman DR, Motzer RJ. Feldman DR, et al. World J Urol. 2009 Aug;27(4):463-70. doi: 10.1007/s00345-009-0431-z. Epub 2009 Jun 10. World J Urol. 2009. PMID: 19513721 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page